Category: National Institute of Health
Steven W. Graves' professional career is focused on the development of Biomedical Diagnostics for critical world health applications. He graduated from the University of Colorado, Boulder with a Degree in Biochemistry (1991) and the Pennsylvania State University with a Ph. D. in Biochemistry, Microbiology, & Molecular Biology (1998). The title of his thesis work was, "The Cloning, Purification, and Initial Kinetic Characterization of the Large Subunit of the Human Mitochondrial DNA Polymerase." After graduation he spent a year developing research grade instrumentation (chemical quench flows and stopped flow spectrophotometers) for Kin-Tek Instruments. He then moved to National Flow Cytometry Resource (NFCR) at Los Alamos (1999) as a Post-Doctoral Research Associate where he specialized in the development of novel flow cytometry instrumentation and application of flow cytometry to biochemical problems of interest.
Center Awards $1.5 million to foster job growth and technology commercialization in the Massachusetts Life Sciences Supercluster
For Immediate Release: Date: May 28, 2010
Contact: Angus G. McQuilken, MLSC VP for Communications
Phone: (617) 921-7749 Email: amcquilken@masslifesciences.com
“This is all about jobs. By helping life sciences companies grow, we create new opportunities for people to work,” said Governor Deval Patrick. “As we continue to strengthen our global leadership in the life sciences, this program will meet an important need and make Massachusetts an even more attractive place for life sciences companies to locate and grow.”
Waltham, MA – The Massachusetts Life Sciences Center’s Board of Directors today awarded $1.5 million in Small Business Matching Grants to three life sciences companies in Massachusetts. The companies receiving grants are Boston Biochem Inc. and Tetragenetics Inc., both of Cambridge and Thermedical Inc. of Somerville. Each company will receive $500,000 from the Center to match federal small business grant funding that the companies had previously been awarded. The grants represent the first round of awards issued under the Center’s Small Business Matching Grant (SBMG) Program. The three companies that are receiving awards have committed to collectively creating 40 new jobs in the Commonwealth by the end of 2011, including six jobs to be relocated from New York.
The Center’s Small Business Matching Grant Program, launched in January 2010 as part of the state’s ten-year, $1 billion Life Sciences Initiative, will match federal small business grant funding for early-stage life sciences companies engaged in life sciences research and development, commercialization and manufacturing in Massachusetts. Goals of the program include the creation of jobs in Massachusetts by the commercialization of products with high potential for market adoption and penetration.
Davis Farmer, Chairman of the Board of MSM Protein Technologies today announced that Chris Hentschel, Ph.D., has joined the Company's Board of Directors. Dr. Hentschel has served as the President and CEO of Malaria Medical Venture for the past ten years.
MMV is a not-for-profit entity based in Geneva, Switzerland that discovers, develops and delivers new and affordable therapies for malaria and assures access to those most at risk from this disease. Prior to joining MMV, Chris served as Chief Scientific Officer at Centocor where he oversaw research into a number of the products that J&J has brought to the market in recent years. He also served as the founding head of the Collaborative Centre of the UK Medical Research Council in London, a pioneering technology transfer facility designed to promote collaborations between the MRC and industry. He received his Ph.D . from King's College London, with a subsequent research fellowship from the European Molecular Biology Organization and NIH.
"Chris is a great addition to our board,” said Farmer.. “He is our first outside Director and as such will provide a valuable perspective to our decision making. He is a true visionary with a great network of relationships in the pharmaceutical, academic and finance community. He has a great track record for innovation and for the creation of successful industry collaborations. We will look to him for guidance on many fronts including strategic decisions regarding the company's long term direction."
CONTACT:
Jeanne Mell
University City Science Center
215-966-6029
PHILADELPHIA--(May 4, 2010) – The University City Science Center has promoted Christopher J. Laing, MRCVS, Ph.D. to Vice President, Science & Technology.
Dr. Laing oversees the Science Center’s Science and Technology Programs, including the Port business incubators and the QED Proof-of-Concept Program. He also provides direct R&D strategy support to Science Center Port business incubator companies and facilitates their access to Greater Philadelphia’s academic and clinical communities through the Science Center’s Scientific Advisory Committee for the Board of Directors.
Dr. Laing began working with the Science Center as a consultant in 2004 and joined the staff as Director of Science & Technology in 2006. He has helped numerous Science Center business clients turn their academic research into thriving businesses. Dr. Laing provides guidance in early business and product development planning, in securing the resources required to retire early technology risks, and in providing a technical communication stream that includes publications, marketing, and applications to federal agencies including NIH, NSF, and FDA.
Special Event Notice
12th Annual
June 2-3, 2010
Raleigh Convention Center
FOR IMMEDIATE RELEASE: Date: 1/27/10
Contact:
Angus G. McQuilken
Vice President for Communications
Cell: 617-921-7749
amcquilken@masslifesciences.com
$3 million available to match federal grant funding for early-stage life sciences companies
Waltham, Massachusetts –The Massachusetts Life Sciences Center, a quasi-public agency tasked with implementing the state’s ten year, $1 billion Life Sciences Initiative, today launched a new Small Business Matching Grant (SBMG) program that will match federal small business grant funding for early-stage life sciences companies in Massachusetts. $3 million will be made available for the program for Fiscal Year 2010. The Center will begin accepting on-line applications for the new program on Monday, February 1, 2010. Applications will be submitted via the Center’s web site at www.masslifesciences.com.
 |
|
Grantwriting 101
including SBIR and STTRs
|
|
qed@qb3 - UCB
Friday, February 5, 2010
12:00 to 1:00 pm
Stanley Hall Room 621
|
SBIR/STTR grants can provide the critical funding necessary to launch your company. But success requires mastering the tricks of the SBIR/STTR program, some of which have frustrated excellent groups. From where to register to uploading your proposal, we'll cover the ins and outs of preparing grants for the NIH. This seminar is aimed at new and experienced grantwriters, from academia and industry. Even veteran grantwriters will benefit from a review of the new formats required as of January 2010.
Shauna Farr-Jones has a 10-year record of writing successful government grant and contract proposals on diverse life science topics, providing strategic input on both research and business plans. She has helped companies secure over $125 million in grant and contract funding from government and philanthropic agencies. Previously, she was at BioCentury Publications, where she analyzed the biotechnology industry. She was a postdoc in PharmChem at UCSF after a Ph.D. in Biochem from Tufts.
Amy F. Boggs is an independent consultant with more than 8 years experience in grant-writing. She also handles the preparation of technical reports, INDs and NDAs, technology assessment, strategic research planning, and competitive landscaping. Prior, Dr. Boggs worked at Microcide and at IntraBiotics, where she managed an interdisciplinary technology in-licensing team. Dr. Boggs is an inventor on three issued patents and has worked on IND-enabling projects. She completed a Ph.D. in PharmChem at UCSF under Dr. Agard.
Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=197134
Date: January 21, 2010
Time: 1:00PM-3:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: from $0 to $40
You may have been a master of grant writing, but things are about to change! The NIH is unrolling a shortened and restructured format for grants starting in 2010. All applications for due dates on or after January 25, 2010 require use of new forms and new instructions. New instructions mean shorter page limits! The research plan is fully restructured and reflects new evaluation criteria. Even people who have written grants in the past are going to need to “relearn” the process. Join us for an interactive workshop on grant writing basics and pitfalls. This event will cover general submissions and writing strategies, with a special focus on NIH SBIRs new submission format, as well as other agencies, grants, and deadlines. | Registration fee: from $0 to $40 | 1:00-3:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Gregory Milman, Ph.D., Director of the Office for Innovation and Special Programs in NIAID
Also: A panel discussion by award winners
2-4 pm on January 13 in Byers Auditorium, Genentech Hall
Reception to follow in the atrium
SBIR and STTR funding can provide critical early stage support for successful bioscience companies. Indeed, many of the companies in the QB3 Mission Bay Incubator Network used SBIR funding to move from lab to startup. This seminar will unpack the secrets of what it takes to maximize your chances of success. Greg Milman oversees the NIAID’s $100M/year SBIR and STTR program.
Contact
Jeanne Mell
University City Science Center
215-966-6029
PHILADELPHIA--(December 21, 2009) – Lisa Staiano-Coico of Temple University has joined the University City Science Center’s Board of Directors. Dr. Staiano-Coico is Provost and Executive Vice President for Academic Affairs, and Professor of Surgery at Temple University.
A widely published expert in skin cell biology, wound healing and burns, Dr. Staiano-Coico has held appointments as professor of nutritional sciences, professor of fiber science and apparel design, professor of microbiology in surgery, professor of public health, and professor of microbiology in dermatology. Prior to coming to Temple, she was dean of the College of Human Ecology at Cornell University. Her research has been funded by the National Institutes of Health (NIH), the New York Firefighters Burn Center Foundation and other agencies.
